218 results on '"Padmanabhan, Anand"'
Search Results
2. Cerebral venous sinus thrombosis associated with SRA-negative heparin-induced thrombocytopenia: case report
3. Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis
4. Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies
5. Vaccine-induced immune thrombotic thrombocytopenia
6. Risk of venous thromboembolism after COVID‐19 vaccination
7. Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination
8. GeoBalance: workload-aware partitioning of real-time spatiotemporal data
9. A prospective, blinded study of a PF4-dependent assay for HIT diagnosis
10. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation
11. Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study
12. IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia
13. EasyScienceGateway: A new framework for providing reproducible user environments on science gateways.
14. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis
15. Recrudescent Heparin-Induced Thrombocytopenia After Therapeutic Plasma Exchange in a Patient Undergoing Thoracic Aortic Replacement.
16. A scalable framework for spatiotemporal analysis of location-based social media data
17. “Autoimmune HIT” antibodies in diagnostic samples are a potential artifact and not associated with more severe outcomes
18. Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis
19. Use of Laboratory Tests to Guide Initiation of Autologous Hematopoietic Progenitor Cell Collection by Apheresis: Results From the Multicenter Hematopoietic Progenitor Cell Collection by Apheresis Laboratory Trigger Survey
20. Monoclonal gammopathy of thrombotic/thrombocytopenic significance
21. Cellular collection by apheresis
22. No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
23. American Society for Apheresis Guidelines Support Use of Red Cell Exchange Transfusion for Severe Malaria With High Parasitemia
24. Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT
25. A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies
26. Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT
27. NHLBI state of the science symposium in therapeutic apheresis: Knowledge gaps and research opportunities in the area of hematology-oncology
28. Venous thromboembolism after COVID‐19 vaccination in patients with thrombophilia.
29. Use of a Dual Lumen Port for Automated Red Cell Exchange in Adults with Sickle Cell Disease
30. Spectra Optia granulocyte apheresis collections result in higher collection efficiency of viable, functional neutrophils in a randomized, crossover, multicenter trial
31. Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy
32. Transfusion Therapy in Postpartum Hemorrhage
33. Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura
34. A Self-Organized Grouping (SOG) Framework for Efficient Grid Resource Discovery
35. Use of IV Immunoglobulin G in Heparin-Induced Thrombocytopenia Patients Is Not Associated With Increased Rates of Thrombosis: A Population-Based Study
36. Evaluation of the spectra optia apheresis system for mononuclear cell (MNC) collection in G-CSF mobilized and nonmobilized healthy donors: Results of a multicenter study
37. Why “R” HIT patients predisposed to thrombosis?
38. Experimentation with local consensus ontologies with implications for automated service composition
39. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
40. Chemoenzymatic Synthesis of Homogeneous Heparan Sulfate and Chondroitin Sulfate Chimeras.
41. Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
42. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI
43. Transfusion requirements in obstetric patients with placenta accreta
44. Poster Board #-Session: P134-I Characteristics of Acute Rejection in ABO Incompatible Renal Allografts Are Related to Time of Diagnosis.: Abstract# 791
45. "Autoimmune HIT", a Potential Diagnostic Artifact Due to Remnant Heparin in HIT Samples, Is Not Associated with More Severe Outcomes
46. Understanding the multifaceted geospatial software ecosystem: a survey approach.
47. Serotonin release assay (SRA)-negative HIT, a newly recognized entity: Implications for diagnosis and management
48. Normal plasma IgG inhibits HIT antibody–mediated platelet activation: implications for therapeutic plasma exchange
49. P-selectin expression assay in a repeatedly serotonin-release assay-negative patient with heparin-induced thrombocytopenia.
50. Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.